The Life Sciences Division Ltd

• Principal Place of Business

  3rd Floor

  45 Albemarle Street

  Mayfair

  London

  W1S 4JL

  UNITED KINGDOM

  Phone

  +447590696057

  Web

  https://www.thelifesciencesdivision.com

• Complaints Contact

  3rd Floor

  45 Albemarle Street

  Mayfair

  London

  London

  W1S 4JL

  UNITED KINGDOM

  Phone

  +447590696057

• Investment Advice (no pensions)

  For Eligible Counterparty, Professional, Certificates representing certain security, Option (excluding a commodity option and an option on a commodity future), Rights to or interests in investments (Contractually Based Investments), Rights to or interests in investments (Security), Share, Warrant

  Show 1 limitation Hide limitations

  • · Investment activity in "rights to or interests in investments (security)" and "rights to or interests in investments (contractually based investment)" is limited to the investment types granted for this activity.

• Authorised to Operate

  Show 1 limitation Hide limitations

  • · The firm can only agree to carry on the regulated activities specified in this Notice.

• Arranges Investments

  For Eligible Counterparty, Professional, Certificates representing certain security, Option (excluding a commodity option and an option on a commodity future), Rights to or interests in investments (Contractually Based Investments), Rights to or interests in investments (Security), Share, Warrant

  Show 1 limitation Hide limitations

  • · Investment activity in "rights to or interests in investments (security)" and "rights to or interests in investments (contractually based investment)" is limited to the investment types granted for this activity.

• Investment Setup

  For Eligible Counterparty, Professional, Certificates representing certain security, Option (excluding a commodity option and an option on a commodity future), Rights to or interests in investments (Contractually Based Investments), Rights to or interests in investments (Security), Share, Warrant

  Show 1 limitation Hide limitations

  • · Investment activity in "rights to or interests in investments (security)" and "rights to or interests in investments (contractually based investment)" is limited to the investment types granted for this activity.

• Alia Jaweed Minhas

  IRN AXJ00098

  • SMF16 Compliance Oversight (since 9 Dec 2019)
  • SMF1 Chief Executive (since 9 Dec 2019)
  • SMF17 Money Laundering Reporting Officer (MLRO) (since 9 Dec 2019)
  • [FCA CF] Manager of certification employee (since 9 Dec 2019)
  • [FCA CF] Client dealing (since 9 Dec 2019)
  • SMF3 Executive Director (since 9 Dec 2019)
  • CF11 Money Laundering Reporting (24 Sep 2018 to 8 Dec 2019)
  • CF10 Compliance Oversight (24 Sep 2018 to 8 Dec 2019)
  • CF3 Chief Executive (24 Sep 2018 to 8 Dec 2019)
  • CF1 Director (22 Apr 2016 to 8 Dec 2019)
  • CF30 Customer (1 Apr 2016 to 8 Dec 2019)
• Ashley Roger George

  IRN AXG12208

  • CF30 Customer (11 Mar 2019 to 8 Dec 2019)
• Charlotte Miranda Jane McAulay

  IRN CMM01169

  • CF30 Customer (15 May 2011 to 2 Dec 2011)
• Deborah Anne Smith

  IRN DAS01317

  • CF1 Director (4 Jan 2011 to 21 Sep 2017)
• Najma Naheed Pirzada

  IRN NNP01000

  • [FCA CF] Client dealing (14 Apr 2023 to 3 Dec 2025)
• Navid Malik

  IRN NXM01182

  • SMF3 Executive Director (9 Dec 2019 to 9 Aug 2024)
  • [FCA CF] Client dealing (9 Dec 2019 to 5 Aug 2024)
  • CF30 Customer (16 Feb 2018 to 8 Dec 2019)
  • CF1 Director (16 Feb 2018 to 8 Dec 2019)
• Robert David Harrington-Jones

  IRN RDH01050

  • [FCA CF] Client dealing (14 Apr 2023 to 16 Sep 2024)
• Torsten Simon Pope

  IRN TSP01014

  • CF1 Director (4 Jan 2011 to 3 Sep 2018)
  • CF10 Compliance Oversight (4 Jan 2011 to 3 Sep 2018)
  • CF11 Money Laundering Reporting (4 Jan 2011 to 3 Sep 2018)
  • CF30 Customer (4 Jan 2011 to 3 Sep 2018)

• Cleopatra Capital Limited (no longer appointed)

  FRN 547767 · Appointed 19 Apr 2011 · Until 2 Dec 2011

No changes recorded yet.